StemCell Therapy

Epigenetics Stem Cells in Development Regenerative Medicine - Allyson Moutri, UC San Diego
Speaker: Alysson Muotri, Ph.D., Assistant Professor, Department of Pediatrics/Cellular Molecular Medicine, UC San Diego.

By: Alliance for Regenerative Medicine

View original post here:
Epigenetics & Stem Cells in Development & Regenerative Medicine - Allyson Moutri, UC San Diego - Video

New research from McLean Hospital and the Harvard Stem Cell Institute has shown that stem cell therapy reduces seizures in mice.

Researchers used an animal model to transplant seizure-inhibiting, human embryonic stem cell-derived neurons into the brains of mice that had a common form of epilepsy. Half of the mice that received the transplanted neurons no longer had seizures, while the other half experienced a significant drop in seizure frequency.

The transplanted neurons integrated into the mouse brains and began to receive neuronal activity. The neurons then released GABA, an inhibitory response that reversed the electrical hyperactivity that causes seizure.

Previous studies showed increasing inhibition in the epileptic brain can help control the seizure and also a lot of anti-epilepsy drugs are mimicking this GABA, so many of them worked by binding to the GABA receptors, researcher Sangmi Chung, assistant professor of psychiatry at Harvard, told FoxNews.com.

Researchers initially set out to test the functionality of human neurons, but later decided to test their effect on epilepsy because it is such a devastating disease. About 30 percent of people do not respond to seizure drugs and one out of 26 people will be affected by seizures in their lifetime, Chung said.

Over 65 million people worldwide are affected by epileptic seizures, which can cause convulsions, loss of consciousness and other neurological symptoms. Patients are treated with anti-seizure drugs, and may choose to have a portion of their brain removed.

Because mouse cells mature more quickly than human cells within weeks instead of years it was unclear how long a stem cell transplant in a human would take before becoming effective, Chung noted.

If we compare it with the mouse [model], we believe it will be years, not weeks, she said.

However, the study found that, even without full maturation, the cells integrated into the epileptic mouse brains, receive signals and release GABA, therefore preventing seizures.

I think its really good news in terms of transplantation even maturing, not fully mature [cells] still work, Chung said.

See more here:
Stem cell transplants may help reduce seizures, study says

Miami, FL (PRWEB) November 05, 2014

Global Stem Cells Group, its subsidiary Stem Cell Training, Inc. and Dr. J. Victor Garcia have announced plans to conduct the Adipose Derived Harvesting, Isolation and Re-integration Training Course in Barcelona, Spain Nov. 22-23. 2014.

The two-day, hands-on intensive training course, which will be conducted by Garcia, was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from adipose tissue and bone marrow. The objective of the training is to bridge the gap between bench science in the laboratory and the doctors office by teaching effective, in-office regenerative medicine techniques.

For more information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-224-1858.

About Global Stem Cells Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.

With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

About Stem Cell Training, Inc.:

Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.

More:
Global Stem Cells Group to Hold Practical, Hands-on Training Course on Adipose-derived Stem Cell Harvesting, Isolation ...

Freeport, Grand Bahama (PRWEB) November 05, 2014

Okyanos is the first to receive regulatory approval from the National Stem Cell Ethics Committee (NSEC) to provide adult stem cell therapy in its new state-of-the-art facility and has now begun treating patients. The licensing includes approval for cardiac cell therapy, as well as cell therapy for tissue ischemia, autoimmune diseases, and other chronic neurological and orthopedic conditions. The licensing criteria requires that approved protocols be supported by peer-reviewed papers showing substantial evidence of safety and efficacy.

"As the leader in cell therapy, Okyanos is very proud to bring a new standard of care and a better quality of life to patients who are looking for new options for unmet healthcare needs. said Matt Feshbach, CEO and co-founder of Okyanos. Adipose (fat)- derived stem and regenerative cells (ADRCs) are known to restore blood flow, modulate the immune system, reduce inflammation and prevent further cell death after a wound, helping the body begin the process of healing itself.

Adult stem cell therapy has emerged as a new treatment alternative for those who want to live a more normal life but are restricted in these activities due to their medical conditions. Just 50 miles from the US shore, Okyanos cell therapy is available to patients with severe heart disease including coronary artery disease (CAD) and congestive heart failure (CHF) as well as patients with auto-immune diseases, orthopedic, neurological and urological conditions. Okyanos cell therapy is performed in their new state-of-the-art facility built to exceed U.S. surgical center standards.

With the regulatory and licensing approvals for adult stem cell therapy, Okyanos is the first to treat patients with cell therapy for severe heart disease and other unmet medical conditions based on a combination of internationally approved cell processing technology, technical papers, clinical trials and in-clinic use which provide the basis for a new standard of care.

Patients can contact Okyanos at http://www.okyanos.com or by calling toll free at 1-855-659-2667.

About Okyanos: (Oh key AH nos) Based in Freeport, Grand Bahama, Okyanos brings a new standard of care and a better quality of life to patients with coronary artery disease, tissue ischemia, autoimmune diseases, and other chronic neurological and orthopedic conditions. Okyanos Cell Therapy utilizes a unique blend of stem and regenerative cells derived from patients own adipose (fat) tissue which helps improve blood flow, moderate destructive immune response and prevent further cell death. Okyanos is fully licensed under the Bahamas Stem Cell Therapy and Research Act and adheres to U.S. surgical center standards. The literary name Okyanos, the Greek god of the river Okyanos, symbolizes restoration of blood flow.

Follow this link:
Okyanos Treats First Patients with Cell Therapy

Stem Cell Research Therapy Explained - From MS to Spinal Injury
Stem cell treatment and research towards curing illness--from multiple sclerosis to spinal injury--is detailed by Dr. Neil Riordan. The American medical industry, obstructions to research in...

By: TheLipTV

Link:
Stem Cell Research & Therapy Explained - From MS to Spinal Injury - Video

Keynote: Molecular Regulation of Stem Cell Quiescence Activation
Keynote Speaker: Thomas Rando, M.D., Ph.D., Director, Glenn Center for the Biology of Aging, Stanford University School of Medicine.

By: Alliance for Regenerative Medicine

Continued here:
Keynote: Molecular Regulation of Stem Cell Quiescence & Activation - Video

Stem Cells Used To Make Mini Human Stomach
Scientists have been able to grow many different kinds of body parts and organs from stem cells. And now, researchers from the Cincinnati Children #39;s Hospital...

By: GeoBeats News

The rest is here:
Stem Cells Used To Make Mini Human Stomach - Video

MIAMI (PRWEB) November 04, 2014

Global Stem Cells Group, Inc. has been named exclusive distributor for Adistem medical solutions, and Adilyfe, a new regenerative medicine products company founded by Adistem Ltd. Scientific Founder Vasilis Paspaliaris, M.D. in Melbourne, Australia and set to launch in early 2015. Paspaliaris made the announcement at the First International Symposium on Stem Cells and Regenerative Medicine held in Buenos Aires, Argentina Oct. 2-4 and hosted by Global Stem Cells Group.

Adistem-Adilyfe will manufacture a group of products for use in stem cell treatments, therapies and training through the Adimarket Division of the Global Stem Cells Group. The timing is perfect for GSCGs current expansion into Latin American countries including Colombia, Costa Rica, Chile, Mexico and Peru, according to Global Stem Cells Group CEO Benito Novas.

Vasilis, an accomplished biotech scientist, stem cell researcher and pharmaceutical consultant joined the Global Stem Cells Group Scientific Advisory Board, part of the Regenestem Network.

As always, Dr. Paspaliaris brings excellence to stem cell research, Novas says. His work has already proven critical to improving the quality of life for a range of chronically ill patients all over the world.

We are honored to be representing Adistem and AdiLyfe products in Latin America; we consider the opportunity a strategic commitment to world class stem cell research.

Vasilis says he knew Global Stem Cells Group would be the only choice to represent Adistem and AdiLyfe in Latin America.

We are proud of our relationship with Global Stem Cells Group, we couldnt ask for better partners, Vasilis says.

To learn more about the Global Stem Cells Group, visit the website at http://www.stemcellsgroup.com, email bnovas(at)stemcellsgroup(dot)com, or call 305.224.1858.

About Global Stem Cell Group:

See original here:
Global Stem Cells Group Named Exclusive Distributor for Adistem and Adilyfe Companies and Product Lines

Fix You with Stem Cells
Description.

By: Oliver Sinclair

See the original post here:
Fix You with Stem Cells - Video

Pioneers of transplantation John Gurdon
Interview with Sir John Gurdon, developmental biologist and forefather of stem cell medicine. The footage, produced by Figment Productions, formed part of an exhibition organised by the MRC...

By: Medical Research Council

Read more:
Pioneers of transplantation John Gurdon - Video

Adler Footcare - Stem Cell Therapy
Backed by years of research, thousands of happy patients, and faster healing time is the latest in ethical stem cell treatments for foot pain offered at Adle...

By: Adler Footcare

Continue reading here:
Adler Footcare - Stem Cell Therapy - Video

Stem Cell Therapy | stem cell mobilization gcsf
http://www.arthritistreatmentcenter.com Another breakthrough in stem cell science and we have lab rats to thank for it next Osteoarthritis in rats responds to stem cell mobilization therapy...

By: Nathan Wei

More:
Stem Cell Therapy | stem cell mobilization gcsf - Video

Stem Cell Therapy BACKSTAGE

By:

Read the rest here:
Stem Cell Therapy BACKSTAGE - Video

PURTIER LIVE STEM CELL THERAPY
PURTIER INTRODUCTION IN CHINESE Please contact Pearly @ +65 9338 9541 / +65 9189 7351 for more details.

By: Purtier30

View original post here:
PURTIER LIVE STEM CELL THERAPY - Video

JANUARY 2014 State of the Industry Briefing at EBD's Biotech Showcase Jan 13. San Francisco, CA EBD's Biotech Showcase: Regenerative Medicine Industry Track Jan 13-15. San Francisco, CA ECI's Conference on Scale-Up and Manufacturing of Cell-Based Therapies Jan 6-9. San Diego, CA International Conference on Cell Therapy for Cardiovascular Disease Jan 22-24. New York, NY Phacilitate's Cell and Gene Therapy Forum Jan 27-29. Washington, DC FEBRUARY 2014 RRY's New York Stem Cell Summit Feb 18. New York, NY STEMSO's International Stem Cell Society Conference Feb 19-22. Freeport, Grand Bahama BMT Tandem Meetings Feb 26-Mar.Grapevine (Dallas), TX MARCH 2014 Danish Stem Cell Symposium Mar 7-8. Hillerd, Denmark ISBioTech Spring Mtg - Cellular Therapies Track Mar 10-12. Washington, DC AAT's Advanced Therapies Summit Mar 12-13. Turin, Italy ISSCR/SBE International Conference on Stem Cell Engineering Mar 16-19. Coronado, CA Congress on Stem Cell and Cell Therapies Mar 2023. Koceli, Turkey FDA and the Changing Paradigm for HCT/P Regulation Mar 24-26. Bethesda, MD BIRAXs' UK-Israel Regenerative Medicine Conference Mar 25-26. Haifa, Israel ARM's RegenMed Investor Day Mar 26. New York, NY. Regenerative Medicine Workshop at Hilton Head Mar 26-29 . Hilton Head, SC Cancer Immunotherapy: A Long-Awaited Reality Mar 27. NYC, NY. FDA Workshop: Synergizing Efforts in Standards Development for Cellular Therapies and Regenerative Medicine Public Mar 31. Silver Spring, MD.

APRIL 2014 Select Biosciences' Clinical Translation of Stem Cells Apr 21-22. Palm Springs, AZ ISCT Annual Meeting Apr 23-26. Paris, France GTCBio's Stem Cell Summit Apr 23-25. Boston, MA ARMs Annual Dinner & Legislative Fly-In Apr 28-9. Washington, DC.

MAY 2014 GeneExpression Systems' Stem Cells and Cell Signaling Mtg on Assays to Regenerative Medicine, Tissue Engineering and Therapeutics May 5-6. Waltham-Boston, MA Regenerative Medicine Foundation Symposium May 5-7. San Francisco, CA CHIsAdoptive T Cell Therapy:New Targets and Strategies for Immune Driven Diseases (part of the Tenth Annual PEGS: the essential protein engineering summit) May 7-8. Boston, MA ASGCT - American Society of Gene and Cell Therapy Mtg May 21-24. Washington, DC Terrapinn's World Stem Cells and Regenerative Medicine Congress May 20-22. London, UK JUNE 2014 PDA Europe: Advanced Therapy Medicinal Products Jun 3-4. Madrid, Spain The Orthobiologic Institute's PRP and Regenerative Medicine Symposium Jun 6-7. Los Angeles, CA Israstem Jun 10-11. Ramat, Gan. Israel TERMIS EU Mtg Jun 10-14. Genova, Italy ISSCR - International Society for Stem Cell Research Mtg Jun 18-21. Vancouver, BC, Canada Cell Tracking Symposium June 20. London, ON

BIO International Convention(with BPI BioProcess Theater) Jun 23-26. San Diego, CA ARM Networking Reception @BIO June 24. San Diego, CA OMIC'sCell Science and Stem Cell Research Jun 24-26. Valencia, Spain JULY 2014 The Business of Regenerative Medicine: New Therapies, New Models July 14-16. Toronto, ON Regenerative Medicine Essentials: The Fundamentals to the Future. July 21-25.Winston-Salem, NC

AUGUST 2014 CHI'sCell Therapy Bioproduction (part of the Bioprocessing Summit) Aug 18-22. Boston, MA Rejuvenation Biotechnology: Emerging Regenerative Medicine Solutions for the Diseases of Aging conference Aug 21-23. Santa Clara, CA.

SEPTEMBER 2014 Terrapinn's Stem Cells USA and Regenerative Medicine Congress Sep 15-16. Boston, MA IBC's Cell Therapy Bioprocessing Sep 15-16. Arlington, VA TERMIS Asia Pacific Mtg Sep 24-17. Daegu, S. Korea

OCTOBER 2014 Cancer Immunotherapy 2014 Oct. 6. New York City, NY ARM's Stem Cell Meeting on the Mesa Oct 7-9. La Jolla, CA Fraunhofer Life Science Symposium"Medicinal Stem Cell Products Oct 9-10. Leipzig, Germany Translational Regenerative Medicine Congress Oct 21-22. Leipzig, Germany CCRM-SCN Till and McCulloch Meetings Oct 27-29. Ottawa, ON, Canada OMICS' International Conference and Exhibition on Cell and Gene Therapy Oct 27-29. Las Vegas, NV

NOVEMBER 2014 ISSCR/SSCS Global Controls in Stem Cells Nov 5-7, 2014. Singapore Society for Immunotherapy of Cancer Annual Meeting Nov 6-9. National Harbor, MD International Conference on Stem Cells and Cancer (ICSCC-2014): Proliferation, Differentiation and Apoptosis Nov 8-10. New Delhi, India IFATS Annual Mtg Nov 13-16. Amsterdam, NL BIT's World Congress of Regenerative Medicine & Stem Cells (RMSC2014) Nov 13-16.Haikou, China Commercial Translation of Regenerative Medicine Nov/Dec ??. London, UK DECEMBER 2014 Cell Therapy Manufacturing Dec 3-4. Brussels, Belgium World Stem Cell Summit Dec 3-5. San Antonio, TX TERMIS Americas Mtg Dec 13-16. Washington, DC If I've missed an event you'd like to see added, please email me at lbuckler [at] celltherapygroup [dot] com.

View post:
Cell Therapy Blog: Cell Therapy Conferences 2014

Dr Joseph Purita MD FACS Mesenchymal Stem Cells
Dr Joseph Purita MD FACS speaking for Global Stem Cells Group in Argentina discussing Stem Cells , http://www.stemcellsgroup.com.

By: StemCellsGroup

Go here to read the rest:
Dr Joseph Purita MD FACS Mesenchymal Stem Cells - Video

ZEISS LSM 880 with Airyscan: Human intestinal stem cells
Human intestinal stem cell derived enteroid monolayer. Staining: Green - F-actin by phalloidin; red - alpha-fodrin protein. 3D imaging comparing confocal wit...

By: ZeissMicroscopy

Read this article:
ZEISS LSM 880 with Airyscan: Human intestinal stem cells - Video

Study of Human Neural Stem Cells
I created this video with the YouTube Video Editor (http://www.youtube.com/editor)

By: Mind, Body Soul

Follow this link:
Study of Human Neural Stem Cells - Video

One kind of stem cell, those referred to as 'facultative', form part -- together with other cells -- of tissues and organs. There is apparently nothing that differentiates these cells from the others. However, they have a very special characteristic, namely they retain the capacity to become stem cells again. This phenomenon is something that happens in the liver, an organ that hosts cells that stimulate tissue growth, thus allowing the regeneration of the organ in the case of a transplant. Knowledge of the underlying mechanism that allows these cells to retain this capacity is a key issue in regenerative medicine.

Headed by Jordi Casanova, research professor at the Instituto de Biologa Molecular de Barcelona (IBMB) of the CSIC and at IRB Barcelona, and by Xavier Franch-Marro, CSIC tenured scientist at the Instituto de Biologa Evolutiva (CSIC-UPF), a study published in the journal Cell Reports reveals a mechanism that could explain this capacity. Working with larval tracheal cells of Drosophila melanogaster, these authors report that the key feature of these cells is that they have not entered the endocycle, a modified cell cycle through which a cell reproduces its genome several times without dividing.

"The function of endocycle in living organisms is not fully understood," comments Xavier Franch-Marro. "One of the theories is that endoreplication contributes to enlarge the cell and confers the production of high amounts of protein." This is the case of almost all larval cells of Drosophila.

The scientists have observed that the cells that enter the endocycle lose the capacity to reactivate as stem cells. "The endocycle is linked to an irreversible change of gene expression in the cell," explains Jordi Casanova, "We have seen that inhibition of endocycle entry confers the cells the capacity to reactivate as stem cells."

Cell entry into the endocycle is associated with the expression of the Fzr gene. The researchers have found that inhibition of this gene prevents this entry, which in turn leads to the conversion of the cell into an adult progenitor that retains the capacity to reactivate as a stem cell. Therefore, this gene acts as a switch that determines whether a cell will enter mitosis (the normal division of a cell) or the endocycle, the latter triggering a totally different genetic program with a distinct outcome regarding the capacity of a cell to reactivate as a stem cell.

Story Source:

The above story is based on materials provided by Institute for Research in Biomedicine (IRB Barcelona). Note: Materials may be edited for content and length.

Here is the original post:
Mechanism that allows differentiated cell to reactivate as a stem cell revealed

Stem Cell Therapy | stem cells fraud
http://www.arthritistreatmentcenter.com Too good to be true. And I was fooled also Japanese stem cell breakthrough, a fraud Reported by Rob Stein in Shots, a prestigious scientific journal...

By: Nathan Wei

Read the original:
Stem Cell Therapy | stem cells fraud - Video